Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Pharmos (PARS) -- Ignore unavailable to you. Want to Upgrade?

To: Ariella who wrote (218)	11/18/1998 10:41:00 AM
From: Don Walster	Read Replies (2) \| Respond to of 1386

Dear Ariella: The following closing statement from your SI post is disturbing. Referring to Pharmos, your say: "But I'm going to keep a very close eye on the risk parameters of my investment in the months ahead." Ariella, This is the first time that I have heard concern expressed about the "risk factor" by you or your cohorts. I think most of us have been aware that stocks like Pharmos are risky. But you seem to accentuate the "risk factor" and support it with documentation. How serious do you think the "risk factor" is? In your opinion is it likely, or is there some possibility that Pharmos will go broke. I bought Pharmos at 3. Would I be wise to minimize possible losses and get out now. Your comment about the "risk factor" certainly persuades me that if Pharmos ever gets back to 3 I will be tempted to run, and maybe before, instead of "hoping" that 2 to 5 years out something spectacular may happen. Incidentally, I appreciate your candor. It inspires more confidence than a cheer leader. Kindest regards, Don